Quick Answer
Zivo Bioscience, Inc. reported Operating Income of -$13.36 million for fiscal year 2024.
Zivo Bioscience, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2024 | -$13.36M | -84.0% |
| 2023 | -$7.26M | +16.8% |
| 2022 | -$8.73M | -1.0% |
| 2021 | -$8.65M | -1.0% |
| 2020 | -$8.56M | -2.4% |
| 2019 | -$8.35M | -36.2% |
| 2018 | -$6.13M | +3.2% |
| 2017 | -$6.33M | -81.4% |
| 2016 | -$3.49M | -14.2% |
| 2015 | -$3.06M | +40.7% |
| 2014 | -$5.15M | -65.7% |
| 2013 | -$3.11M | -49.5% |
| 2012 | -$2.08M | -7.3% |
| 2011 | -$1.94M | +52.3% |
| 2010 | -$4.06M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.02M | +54.9% | +37.6% |
| June 30, 2025 | -$1.63M | +80.2% | +61.2% |
| March 31, 2025 | -$4.21M | -229.9% | -86.2% |
| September 30, 2024 | -$2.26M | -43.7% | +72.5% |
| June 30, 2024 | -$8.23M | -351.2% | -545.0% |
| March 31, 2024 | -$1.28M | +35.2% | +18.9% |
| September 30, 2023 | -$1.57M | +21.4% | +13.8% |
| June 30, 2023 | -$1.82M | +11.8% | +7.4% |
- Zivo Bioscience, Inc. showed a decrease of -84.0% in Operating Income compared to the prior fiscal year.
- Over the 2010–2024 period, Zivo Bioscience, Inc.’s operating income has declined by 229.0% (from -$4.06 million to -$13.36 million).
- The most recent figure is from Zivo Bioscience, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 18, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: